NEW YORK (GenomeWeb News) — Miraculins yesterday said it plans to generate as much as $500,000 through a private stock placement.
 
The company plans to use the proceeds to fund research and development projects, and for working capital purposes.
 
Miraculins will offer as many as 1.25 million equity “units” for $.40 apiece. Each unit will include one common company share and one half of one share purchase warrant, which will be set at $.65 for a 12-month period from the date the offering closes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.